Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14584801rdf:typepubmed:Citationlld:pubmed
pubmed-article:14584801lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:14584801lifeskim:mentionsumls-concept:C1704689lld:lifeskim
pubmed-article:14584801lifeskim:mentionsumls-concept:C1155299lld:lifeskim
pubmed-article:14584801lifeskim:mentionsumls-concept:C0030230lld:lifeskim
pubmed-article:14584801lifeskim:mentionsumls-concept:C0001186lld:lifeskim
pubmed-article:14584801lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:14584801lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:14584801lifeskim:mentionsumls-concept:C0205100lld:lifeskim
pubmed-article:14584801lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:14584801lifeskim:mentionsumls-concept:C0127400lld:lifeskim
pubmed-article:14584801pubmed:issue19lld:pubmed
pubmed-article:14584801pubmed:dateCreated2003-10-30lld:pubmed
pubmed-article:14584801pubmed:abstractTextPd(0) mediated couplings between substituted 2-(pivaloylamino)benzeneboronic acids and 3,6-disubstituted-10-methylacridones 13 bearing a bromo or trifluoromethylsulfonyloxy substituent in the 1-position yield intermediate 1-arylacridones 16 which can be can be cyclised to new 8-methylquino[4,3,2-kl]acridines 17 with phosphorus oxychloride or 6 M HCI in EtOH. Heck reactions between triflate-substituted substrates 17 and acrylic acid derivatives afforded quinoacridines with unsaturated side-chains in the 6-position. Alkylboranes, prepared by interaction of 9-borabicyclo[3,3,1]nonane (9-BBN) and allyl acetate or N-allyltrifluoroacetamide, participated in Suzuki-Miyaura reactions with chloro-substituted 8-methylquinoacridines to form derivatives bearing functionalised propyl groups in the 6- and 10-positions. Representative 8-methylquinoacridines were methylated with methyl iodide to yield telomerase-inhibitory 8,13-dimethylquinoacridinium iodides 24.lld:pubmed
pubmed-article:14584801pubmed:languageenglld:pubmed
pubmed-article:14584801pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14584801pubmed:citationSubsetIMlld:pubmed
pubmed-article:14584801pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14584801pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14584801pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14584801pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14584801pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14584801pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14584801pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14584801pubmed:statusMEDLINElld:pubmed
pubmed-article:14584801pubmed:monthOctlld:pubmed
pubmed-article:14584801pubmed:issn1477-0520lld:pubmed
pubmed-article:14584801pubmed:authorpubmed-author:StevensMalcol...lld:pubmed
pubmed-article:14584801pubmed:authorpubmed-author:HealdRobert...lld:pubmed
pubmed-article:14584801pubmed:issnTypePrintlld:pubmed
pubmed-article:14584801pubmed:day7lld:pubmed
pubmed-article:14584801pubmed:volume1lld:pubmed
pubmed-article:14584801pubmed:ownerNLMlld:pubmed
pubmed-article:14584801pubmed:authorsCompleteYlld:pubmed
pubmed-article:14584801pubmed:pagination3377-89lld:pubmed
pubmed-article:14584801pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:14584801pubmed:meshHeadingpubmed-meshheading:14584801...lld:pubmed
pubmed-article:14584801pubmed:meshHeadingpubmed-meshheading:14584801...lld:pubmed
pubmed-article:14584801pubmed:meshHeadingpubmed-meshheading:14584801...lld:pubmed
pubmed-article:14584801pubmed:meshHeadingpubmed-meshheading:14584801...lld:pubmed
pubmed-article:14584801pubmed:meshHeadingpubmed-meshheading:14584801...lld:pubmed
pubmed-article:14584801pubmed:meshHeadingpubmed-meshheading:14584801...lld:pubmed
pubmed-article:14584801pubmed:meshHeadingpubmed-meshheading:14584801...lld:pubmed
pubmed-article:14584801pubmed:meshHeadingpubmed-meshheading:14584801...lld:pubmed
pubmed-article:14584801pubmed:meshHeadingpubmed-meshheading:14584801...lld:pubmed
pubmed-article:14584801pubmed:meshHeadingpubmed-meshheading:14584801...lld:pubmed
pubmed-article:14584801pubmed:meshHeadingpubmed-meshheading:14584801...lld:pubmed
pubmed-article:14584801pubmed:meshHeadingpubmed-meshheading:14584801...lld:pubmed
pubmed-article:14584801pubmed:meshHeadingpubmed-meshheading:14584801...lld:pubmed
pubmed-article:14584801pubmed:meshHeadingpubmed-meshheading:14584801...lld:pubmed
pubmed-article:14584801pubmed:year2003lld:pubmed
pubmed-article:14584801pubmed:articleTitleAntitumour polycyclic acridines. Palladium(0) mediated syntheses of quino[4,3,2-kl]acridines bearing peripheral substituents as potential telomere maintenance inhibitors.lld:pubmed
pubmed-article:14584801pubmed:affiliationCancer Research Laboratories, School of Pharmaceutical Sciences, University of Nottingham, Nottingham, UK NG7 2RD.lld:pubmed
pubmed-article:14584801pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:14584801pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed